Incidental Mutation 'R8343:Acvr1'
ID 644991
Institutional Source Beutler Lab
Gene Symbol Acvr1
Ensembl Gene ENSMUSG00000026836
Gene Name activin A receptor, type 1
Synonyms Alk8, Tsk7L, SKR1, D330013D15Rik, ActRIA, ALK2, Acvr1a, Acvr, Alk-2, Acvrlk2, ActR-I
MMRRC Submission 067866-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R8343 (G1)
Quality Score 225.009
Status Validated
Chromosome 2
Chromosomal Location 58336450-58456840 bp(-) (GRCm39)
Type of Mutation critical splice acceptor site
DNA Base Change (assembly) T to A at 58364286 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000056784 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000056376] [ENSMUST00000056376] [ENSMUST00000056376] [ENSMUST00000090935] [ENSMUST00000090935] [ENSMUST00000090935] [ENSMUST00000112599] [ENSMUST00000112599] [ENSMUST00000112599] [ENSMUST00000112601] [ENSMUST00000112601] [ENSMUST00000112601] [ENSMUST00000126407] [ENSMUST00000167423]
AlphaFold P37172
Predicted Effect probably null
Transcript: ENSMUST00000056376
SMART Domains Protein: ENSMUSP00000056784
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000056376
SMART Domains Protein: ENSMUSP00000056784
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000056376
SMART Domains Protein: ENSMUSP00000056784
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000090935
SMART Domains Protein: ENSMUSP00000088453
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000090935
SMART Domains Protein: ENSMUSP00000088453
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000090935
SMART Domains Protein: ENSMUSP00000088453
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112599
SMART Domains Protein: ENSMUSP00000108218
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 1.4e-13 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112599
SMART Domains Protein: ENSMUSP00000108218
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 1.4e-13 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112599
SMART Domains Protein: ENSMUSP00000108218
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 1.4e-13 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112601
SMART Domains Protein: ENSMUSP00000108220
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112601
SMART Domains Protein: ENSMUSP00000108220
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably null
Transcript: ENSMUST00000112601
SMART Domains Protein: ENSMUSP00000108220
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000126407
SMART Domains Protein: ENSMUSP00000120755
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 3.9e-15 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000167423
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.7%
  • 20x: 98.9%
Validation Efficiency 97% (64/66)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous inactivation of this gene leads to embryonic growth arrest and complete embryonic lethality due to gastrulation defects associated with abnormalities in primitive streak formation, embryonic epiblast morphology, and mesoderm and ectoderm development. [provided by MGI curators]
Allele List at MGI

All alleles(12) : Targeted, knock-out(4) Targeted, other(3) Gene trapped(5)

Other mutations in this stock
Total: 70 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aars1 T A 8: 111,767,361 (GRCm39) W156R probably damaging Het
Adamts2 G T 11: 50,494,315 (GRCm39) V130L probably damaging Het
Adcy4 C T 14: 56,012,697 (GRCm39) V541I probably benign Het
Adgrl2 C T 3: 148,552,542 (GRCm39) V654I probably damaging Het
Ago3 T A 4: 126,270,721 (GRCm39) K258* probably null Het
Akap11 A T 14: 78,749,929 (GRCm39) S819R Het
Alox5ap T C 5: 149,224,419 (GRCm39) F121L probably damaging Het
Baz2b A T 2: 59,731,858 (GRCm39) M2060K probably damaging Het
Bltp3b T C 10: 89,627,281 (GRCm39) S449P probably benign Het
C030005K15Rik T C 10: 97,561,414 (GRCm39) I106V unknown Het
Carmil2 T A 8: 106,417,716 (GRCm39) S604T probably benign Het
Ccdc121rt2 C T 5: 112,598,653 (GRCm39) T400I probably benign Het
Cdhr1 T C 14: 36,813,935 (GRCm39) T164A probably benign Het
Dhx30 T C 9: 109,914,569 (GRCm39) E976G possibly damaging Het
Dnah17 C T 11: 118,005,021 (GRCm39) G788R probably benign Het
Dus2 T C 8: 106,722,645 (GRCm39) probably benign Het
Etv6 T C 6: 134,225,717 (GRCm39) V316A possibly damaging Het
Fabp9 T G 3: 10,259,085 (GRCm39) K107T possibly damaging Het
Fmn2 CCCTCCTCTCCCTGGAATGGGAATACCTCCCCCACCTCCTCTCCCTGGAATGGGAATACCTCCCCCACCTCCTCTCCCTGGAATGGGAATATCTCCCCTACCTCCTCTCCCTGGAATGGGAATACCTCC CCCTCCTCTCCCTGGAATGGGAATACCTCCCCCACCTCCTCTCCCTGGAATGGGAATATCTCCCCTACCTCCTCTCCCTGGAATGGGAATACCTCC 1: 174,436,769 (GRCm39) probably benign Het
Gapdh A G 6: 125,140,226 (GRCm39) V92A probably benign Het
Gfy A G 7: 44,826,019 (GRCm39) L453P probably damaging Het
Gp2 C T 7: 119,042,010 (GRCm39) C505Y probably benign Het
Gtpbp8 T C 16: 44,566,676 (GRCm39) R9G probably benign Het
Hipk4 G T 7: 27,223,033 (GRCm39) R31L probably damaging Het
Htt T A 5: 35,063,068 (GRCm39) M2900K probably damaging Het
Ighv1-20 T C 12: 114,687,810 (GRCm39) I6V probably benign Het
Il17d C T 14: 57,779,937 (GRCm39) T153I probably damaging Het
Izumo3 T A 4: 92,034,581 (GRCm39) N117I probably damaging Het
Kcnh7 T C 2: 62,680,879 (GRCm39) D236G probably benign Het
Kmt2d T C 15: 98,750,478 (GRCm39) D2405G unknown Het
Map4k2 T C 19: 6,396,596 (GRCm39) W533R probably damaging Het
Matn1 C A 4: 130,673,300 (GRCm39) Y89* probably null Het
Mettl18 T A 1: 163,824,509 (GRCm39) Y277N probably damaging Het
Muc5b G A 7: 141,417,898 (GRCm39) G3615S probably benign Het
Mycbp2 A C 14: 103,398,111 (GRCm39) probably null Het
Myh4 T A 11: 67,143,390 (GRCm39) S1041T possibly damaging Het
Myl10 G C 5: 136,726,825 (GRCm39) V70L probably benign Het
Naaladl1 T C 19: 6,159,703 (GRCm39) V378A possibly damaging Het
Nars1 T C 18: 64,637,458 (GRCm39) D374G probably benign Het
Neb C T 2: 52,198,283 (GRCm39) probably null Het
Neurl1b A G 17: 26,650,965 (GRCm39) Y79C probably damaging Het
Nynrin A G 14: 56,101,248 (GRCm39) T306A probably benign Het
Ola1 G T 2: 73,029,745 (GRCm39) R125S probably damaging Het
Or12d15 T A 17: 37,694,122 (GRCm39) F221L probably benign Het
Or51a43 A T 7: 103,717,383 (GRCm39) V285D probably damaging Het
Pak1ip1 C A 13: 41,158,214 (GRCm39) T29K probably benign Het
Podnl1 T A 8: 84,857,402 (GRCm39) L337H Het
Rictor T G 15: 6,807,800 (GRCm39) probably null Het
Rsf1 ATGGCG ATGGCGACGGTGGCG 7: 97,229,111 (GRCm39) probably benign Het
Sel1l2 T C 2: 140,072,753 (GRCm39) I627M probably benign Het
Sh3rf2 T C 18: 42,244,493 (GRCm39) S352P probably damaging Het
Slc6a6 G A 6: 91,703,224 (GRCm39) W199* probably null Het
Smc2 T A 4: 52,450,965 (GRCm39) V261E probably benign Het
Sorcs3 G A 19: 48,692,808 (GRCm39) probably null Het
Spdye4a T A 5: 143,211,562 (GRCm39) M1L probably benign Het
Stag1 T C 9: 100,639,819 (GRCm39) I125T possibly damaging Het
Stx8 T A 11: 67,911,814 (GRCm39) D177E probably benign Het
Sun2 T C 15: 79,623,125 (GRCm39) Y71C probably damaging Het
Tmed9 T C 13: 55,742,617 (GRCm39) F129L probably benign Het
Tmem216 T A 19: 10,529,336 (GRCm39) T17S probably benign Het
Tmpo A T 10: 90,997,974 (GRCm39) N604K probably benign Het
Tmprss11f T A 5: 86,681,666 (GRCm39) I196F probably benign Het
Tnks A G 8: 35,301,738 (GRCm39) F1244L probably benign Het
Tspan2 T C 3: 102,676,226 (GRCm39) C212R probably damaging Het
Tspan4 A G 7: 141,071,718 (GRCm39) D155G probably damaging Het
Ttc6 T C 12: 57,707,282 (GRCm39) F730L possibly damaging Het
Txnrd2 G A 16: 18,245,291 (GRCm39) A33T unknown Het
Wnk1 C T 6: 119,940,454 (GRCm39) R761H probably damaging Het
Zfp217 T C 2: 169,962,024 (GRCm39) D101G probably damaging Het
Zfp281 T C 1: 136,555,620 (GRCm39) F866S probably damaging Het
Other mutations in Acvr1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00691:Acvr1 APN 2 58,337,585 (GRCm39) missense probably benign 0.00
IGL01392:Acvr1 APN 2 58,390,558 (GRCm39) missense probably benign 0.01
IGL01526:Acvr1 APN 2 58,348,997 (GRCm39) missense probably benign 0.20
IGL02524:Acvr1 APN 2 58,338,319 (GRCm39) splice site probably benign
IGL02682:Acvr1 APN 2 58,367,823 (GRCm39) missense probably benign 0.00
IGL02795:Acvr1 APN 2 58,352,964 (GRCm39) missense probably damaging 1.00
R0084:Acvr1 UTSW 2 58,348,895 (GRCm39) critical splice donor site probably null
R0452:Acvr1 UTSW 2 58,390,507 (GRCm39) missense probably benign 0.13
R0746:Acvr1 UTSW 2 58,390,562 (GRCm39) start codon destroyed probably null 0.01
R1484:Acvr1 UTSW 2 58,369,901 (GRCm39) missense probably damaging 1.00
R1514:Acvr1 UTSW 2 58,337,597 (GRCm39) nonsense probably null
R1645:Acvr1 UTSW 2 58,352,911 (GRCm39) missense probably damaging 1.00
R1925:Acvr1 UTSW 2 58,337,661 (GRCm39) missense probably damaging 0.99
R2435:Acvr1 UTSW 2 58,369,704 (GRCm39) missense probably damaging 1.00
R2873:Acvr1 UTSW 2 58,367,808 (GRCm39) nonsense probably null
R3729:Acvr1 UTSW 2 58,352,925 (GRCm39) missense probably null 0.09
R3854:Acvr1 UTSW 2 58,352,946 (GRCm39) missense probably damaging 1.00
R4438:Acvr1 UTSW 2 58,367,739 (GRCm39) missense probably benign 0.00
R4863:Acvr1 UTSW 2 58,367,723 (GRCm39) missense possibly damaging 0.60
R5543:Acvr1 UTSW 2 58,353,157 (GRCm39) missense probably damaging 1.00
R5558:Acvr1 UTSW 2 58,349,029 (GRCm39) missense probably damaging 1.00
R5618:Acvr1 UTSW 2 58,352,955 (GRCm39) missense probably damaging 1.00
R6233:Acvr1 UTSW 2 58,338,411 (GRCm39) missense probably benign 0.04
R6236:Acvr1 UTSW 2 58,367,678 (GRCm39) missense probably benign 0.17
R6565:Acvr1 UTSW 2 58,369,769 (GRCm39) missense probably damaging 1.00
R6912:Acvr1 UTSW 2 58,337,585 (GRCm39) missense probably benign 0.00
R7739:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R7912:Acvr1 UTSW 2 58,364,230 (GRCm39) missense probably damaging 0.97
R8127:Acvr1 UTSW 2 58,367,638 (GRCm39) missense probably benign 0.14
R8688:Acvr1 UTSW 2 58,352,961 (GRCm39) missense probably damaging 0.98
R8876:Acvr1 UTSW 2 58,338,422 (GRCm39) missense possibly damaging 0.83
R9135:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R9290:Acvr1 UTSW 2 58,338,330 (GRCm39) missense probably damaging 1.00
R9562:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
R9565:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
Z1176:Acvr1 UTSW 2 58,369,880 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- GCACCTCCTGCATTTAATGAGG -3'
(R):5'- TCGCTTCTAAGTTTCCCAAGAC -3'

Sequencing Primer
(F):5'- GAAGCAGACTTTTCCAAGCCCTG -3'
(R):5'- AGTTTCCCAAGACATATAACTAGTCC -3'
Posted On 2020-09-02